Role of human nucleoside transporters in the uptake and cytotoxicity of azacitidine and decitabine (Q48655141)

13 February 2018

title

Role of human nucleoside transporters in the uptake and cytotoxicity of azacitidine and decitabine (English)

1 reference

13 February 2018

0 references

Vijaya L Damaraju

1

1 reference

13 February 2018

Delores Mowles

2

1 reference

13 February 2018

Sylvia Yao

3

1 reference

13 February 2018

Amy Ng

4

1 reference

13 February 2018

James D Young

5

1 reference

13 February 2018

Carol E Cass

6

1 reference

13 February 2018

Zeen Tong

7

1 reference

13 February 2018

publication date

1 January 2012

1 reference

13 February 2018

Nucleosides, Nucleotides & Nucleic Acids

published in

1 reference

13 February 2018

volume

31

1 reference

13 February 2018

issue

3

1 reference

13 February 2018

page(s)

236-255

1 reference

13 February 2018

Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study

cites work

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2011.652330

Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2011.652330

New nucleoside analogs for patients with hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2011.652330

Cellular differentiation, cytidine analogs and DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2011.652330

A comparison of azacitidine and decitabine activities in acute myeloid leukemia cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2011.652330

The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2011.652330

Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2011.652330

Vectorial transport of nucleoside analogs from the apical to the basolateral membrane in double-transfected cells expressing the human concentrative nucleoside transporter hCNT3 and the export pump ABCC4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2011.652330

Human concentrative nucleoside transporter 1-mediated uptake of 5-azacytidine enhances DNA demethylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2011.652330

The equilibrative nucleoside transporter family, SLC29

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2011.652330

The concentrative nucleoside transporter family, SLC28

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2011.652330

Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2011.652330

Distribution and functional characterization of equilibrative nucleoside transporter-4, a novel cardiac adenosine transporter activated at acidic pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2011.652330

Cloning of the human equilibrative, nitrobenzylmercaptopurine riboside (NBMPR)-insensitive nucleoside transporter ei by functional expression in a transport-deficient cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2011.652330

Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2011.652330

Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2011.652330

Functional and molecular characterization of nucleobase transport by recombinant human and rat equilibrative nucleoside transporters 1 and 2. Chimeric constructs reveal a role for the ENT2 helix 5-6 region in nucleobase translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2011.652330

Identification and characterization of a novel monoamine transporter in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2011.652330

Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2011.652330

Molecular identification and characterization of novel human and mouse concentrative Na+-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2011.652330

Molecular cloning, functional expression and chromosomal localization of a cDNA encoding a human Na+/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2011.652330

Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2011.652330

Mutation of residue 33 of human equilibrative nucleoside transporters 1 and 2 alters sensitivity to inhibition of transport by dilazep and dipyridamole

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2011.652330

Uridine binding motifs of human concentrative nucleoside transporters 1 and 3 produced in Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2011.652330

Interactions of nucleoside analogs, caffeine, and nicotine with human concentrative nucleoside transporters 1 and 2 stably produced in a transport-defective human cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2011.652330

Uridine recognition motifs of human equilibrative nucleoside transporters 1 and 2 produced in Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2011.652330

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2011.652330

The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2011.652330

Interaction of fused-pyrimidine nucleoside analogs with human concentrative nucleoside transporters: High-affinity inhibitors of human concentrative nucleoside transporter 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2011.652330

Comparison of the interaction of uridine, cytidine, and other pyrimidine nucleoside analogues with recombinant human equilibrative nucleoside transporter 2 (hENT2) produced in Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2011.652330

Kinetics of phosphorylation of 5-aza-2′-deoxycytidine by deoxycytidine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2011.652330

Human nucleoside transporters: biomarkers for response to nucleoside drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2011.652330

Es nucleoside transporter content of acute leukemia cells: role in cell sensitivity to cytarabine (araC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2011.652330

Human equilibrative nucleoside transporter 1 and human concentrative nucleoside transporter 3 predict survival after adjuvant gemcitabine therapy in resected pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2011.652330

The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2011.652330

10.1080/15257770.2011.652330

21 January 2018

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018